Liwei Lorraine Lin
General Counsel · NovaBridge Biosciences
Individual
- 2026
- Jul 10, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Liwei Lorraine Lin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Arnold Hagler - $577K in NBP purchases and sales in the last 12 months
- Sean Wuxiong Cao - $122K in NBP purchases and sales in the last 12 months
- Cong Claire Xu - $20K in NBP purchases and sales in the last 12 months
- Phillip Andrew Dennis - $11K in NBP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Liwei Lorraine Lin?
Liwei Lorraine Lin is a corporate insider, tracked as General Counsel of NovaBridge Biosciences (NBP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Liwei Lorraine Lin last file a Form 4?
The only primary Form 4 on record is dated 10 July 2026.